APA

Sarin N., Engel F., Kalayda G. V., Mannewitz M., Cinatl J., Rothweiler F., Michaelis M., Saafan H., Ritter C. A., Jaehde U. & Frötschl R. (20171013). Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. : PloS one.

Chicago

Sarin Navin, Engel Florian, Kalayda Ganna V, Mannewitz Mareike, Cinatl Jindrich, Rothweiler Florian, Michaelis Martin, Saafan Hisham, Ritter Christoph A, Jaehde Ulrich and Frötschl Roland. 20171013. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. : PloS one.

Harvard

Sarin N., Engel F., Kalayda G. V., Mannewitz M., Cinatl J., Rothweiler F., Michaelis M., Saafan H., Ritter C. A., Jaehde U. and Frötschl R. (20171013). Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. : PloS one.

MLA

Sarin Navin, Engel Florian, Kalayda Ganna V, Mannewitz Mareike, Cinatl Jindrich, Rothweiler Florian, Michaelis Martin, Saafan Hisham, Ritter Christoph A, Jaehde Ulrich and Frötschl Roland. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. : PloS one. 20171013.